Ghrelin plasma levels in patients with idiopathic short stature
Author
dc.contributor.author
Iñíguez Vila, Germán
Author
dc.contributor.author
Román, Rossana
Author
dc.contributor.author
Youlton, Ronald
Author
dc.contributor.author
Cassorla Goluboff, Fernando
Author
dc.contributor.author
Mericq, Verónica
Admission date
dc.date.accessioned
2019-03-11T13:00:58Z
Available date
dc.date.available
2019-03-11T13:00:58Z
Publication date
dc.date.issued
2011
Cita de ítem
dc.identifier.citation
Hormone Research in Paediatrics, Volumen 75, Issue 2, 2018, Pages 94-100
Identifier
dc.identifier.issn
16632818
Identifier
dc.identifier.issn
16632826
Identifier
dc.identifier.other
10.1159/000317429
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/165188
Abstract
dc.description.abstract
Background: Novel molecular insights have suggested that ghrelin may be involved in the pathogenesis of some forms of short stature. Recently, growth hormone secretagogue receptor (GHSR) mutations that segregate with short stature have been reported. Aim: To study plasma ghrelin levels in prepubertal patients with idiopathic short stature (ISS). Methods: Fasting total plasma ghrelin levels (radioimmunoassay) in 41 prepubertal patients with ISS (18 females, age 7.9 ± 0.5 years) compared with 42 age- and sex-matched controls (27 females, age 8.0 ± 0.3 years) with normal height. In a subset of 28 patients, the ghrelin receptor was sequenced. Results: ISS patients exhibited a higher level of ghrelin (1,458 ± 137 vs. 935 ± 55 pg/ml, p < 0.01) and similar IGF-I levels (-0.66 ± 1.29 vs. -0.32 ± 0.78 SDS) compared to controls. Ten patients with ISS had ghrelin levels greater than +2 SDS compared to controls. These patients did not differ in height, BMI or IGF-I SDS compared to ISS patients wit